Patents Examined by Christopher S. E. Low
  • Patent number: 6051405
    Abstract: The present invention describes constructs encoding recombinant scFv-toxin fusion proteins which selectively kill cells bearing appropriate antigens or receptors.
    Type: Grant
    Filed: April 8, 1992
    Date of Patent: April 18, 2000
    Assignees: The United States of America as represented by the Secretary of the Department of Health and Human Services, Protein Design Labs, Inc.
    Inventors: David FitzGerald, Vijay Kumar Chaudhary, Ira Harry Pastan, Thomas Alexander Waldmann, Cary L Queen